Solventum Stock Forecast
NYSE: SOLVHealth CareMedical/Dental InstrumentsUSD
Market open · Delayed 15 min · as of Oct 8, 3:49 PM ET
SOLV analyst consensus
Consensus (15 analysts)
buy
Avg. price target
$94.31+8.87%
- Strong buy 1
- Buy 7
- Hold 5
- Sell 1
- Strong sell 1
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 15 Wall Street analysts covering Solventum (2026-10-07), 8 rate the stock a buy or strong buy, 5 rate it a hold and 2 rate it a sell or strong sell, for a consensus rating of "buy". The average 12-month price target is $94.31, with a high estimate of $113.00 and a low estimate of $71.00. The average target implies upside of 8.9% from the current price of $86.63.
The spread between the highest and lowest targets is 59.2%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for SOLV.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 1 | 7% |
| Buy | 7 | 47% |
| Hold | 5 | 33% |
| Sell | 1 | 7% |
| Strong sell | 1 | 7% |
Ratings as of 2026-10-07.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $71.00 | -18.04% |
| Average target | $94.31 | +8.87% |
| High target | $113.00 | +30.44% |